[{"id":"88f42f2b-3280-4f89-8f51-0e7028896643","acronym":"BELLWAVE-001","url":"https://clinicaltrials.gov/study/NCT03162536","created_at":"2021-01-18T15:35:37.913Z","updated_at":"2024-07-02T16:35:15.719Z","phase":"Phase 1/2","brief_title":"A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)","source_id_and_acronym":"NCT03162536 - BELLWAVE-001","lead_sponsor":"ArQule, Inc., a subsidiary of Merck Sharp \u0026 Dohme LLC, a subsidiary of Merck \u0026 Co., Inc. (Rahway, NJ USA)","biomarkers":" BCL2 • BCL6","pipe":" | ","alterations":" BTK mutation • BCL6 translocation • BTK C481","tags":["BCL2 • BCL6"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BTK mutation • BCL6 translocation • BTK C481"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e nemtabrutinib (MK-1026)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 190","initiation":"Initiation: 06/26/2017","start_date":" 06/26/2017","primary_txt":" Primary completion: 09/12/2025","primary_completion_date":" 09/12/2025","study_txt":" Completion: 09/12/2025","study_completion_date":" 09/12/2025","last_update_posted":"2024-03-08"},{"id":"c0336778-22a8-4c11-818f-1fc3b1122699","acronym":"NX-2127-001","url":"https://clinicaltrials.gov/study/NCT04830137","created_at":"2021-04-02T11:53:54.216Z","updated_at":"2024-07-02T16:35:30.165Z","phase":"Phase 1","brief_title":"A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies","source_id_and_acronym":"NCT04830137 - NX-2127-001","lead_sponsor":"Nurix Therapeutics, Inc.","biomarkers":" TP53 • CD4","pipe":" | ","alterations":" TP53 mutation • BTK C481","tags":["TP53 • CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TP53 mutation • BTK C481"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e zelebrudomide (NX-2127)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 160","initiation":"Initiation: 05/05/2021","start_date":" 05/05/2021","primary_txt":" Primary completion: 12/01/2024","primary_completion_date":" 12/01/2024","study_txt":" Completion: 12/01/2025","study_completion_date":" 12/01/2025","last_update_posted":"2023-11-07"}]